Evidence map›Paper›PMID 23911990›Full record

ReviewExperimental cell research2013

Distinct functions for Rap1 signaling in vascular morphogenesis and dysfunction.

Magdalena Chrzanowska-Wodnicka

Open access · greenAbstract readReview
In one paragraph

Review in Experimental cell research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. High PGEScientifica · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. The Role of RASGRP2 in Vascular Endothelial Cells-A Mini Review.International journal of molecular sciences · 2021
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Magdalena Chrzanowska-WodnickaBlood Center of Wisconsin, Blood Research Institute, PO Box 2178, Milwaukee 53201, USA. Magdalena.Wodnicka@bcw.edu
Versiti Blood Center of Wisconsin · US

Funding

Rap1 in VEGF signaling in endothelial cellsR01HL111582 · NHLBI · VERSITI WISCONSIN, INC. · PI CHRZANOWSKA, MAGDALENA · 2012 to 2019
$3.3M
NHLBI NIH HHS HL111582NHLBI NIH HHS R01 HL111582
6 · The paper itself

Abstract

Rap1 signaling is important for both major processes of vessel formation: vasculogenesis, or de novo vessel formation, and angiogenesis, sprouting of new vessels from pre-existing ones. We provide an overview of genetic studies in mice and zebrafish and discuss some of the proposed underlying mechanisms derived from cellular models, with particular emphasis on Rap1's role in angiogenesis, maintenance of endothelial barrier and connection with cerebral cavernous malformation (CCM), a neurological deficit that leads to seizures and lethal stroke. Lastly, we provide a brief summary of studies in cardiac and smooth muscle cells, where the Epac-Rap1 signaling axis is emerging as an important regulator of contractility.

Indexed as

Signal TransductionAnimalsBlood VesselsCentral Nervous System NeoplasmsEndothelial CellsEndothelium, VascularGene Expression RegulationGuanine Nucleotide Exchange FactorsHemangioma, Cavernous, Central Nervous SystemMiceMorphogenesisNeovascularization, PathologicNeovascularization, Physiologicrap1 GTP-Binding ProteinsZebrafishEpac protein, mouseGuanine Nucleotide Exchange Factorsrap1 GTP-Binding ProteinsAngiogenesisCerebral cavernous malformationsContractilityEndothelial junctionsVasculogenesis

Identifiers

PMID23911990
PMCPMC3913003
OpenAlexW2075964588

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.